microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.

By B. Kefas, J. Godlewski, L. Comeau, Yunqing Li, R. Abounader, Michael P Hawkinson, Jeongwu Lee, H. Fine, E. Chiocca, S. Lawler and 1 more. Cancer Research, 2008

766 citations recorded by the source corpus.

Subfields: Cancer Research, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/8ced8a438b4489f3b55883faffb2ea7320aa3416

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. Nikolaus Rajewsky
2. Danish H Sayed
3. Markus Landthaler
4. M. Abdellatif
5. David P. Bartel
6. Phillip D. Zamore
7. Julia Salzman

In Molecular Biology

1. Nikolaus Rajewsky
2. Matthias Selbach
3. Markus Landthaler
4. Danish H Sayed
5. M. Abdellatif
6. David P. Bartel
7. Julia Salzman
8. Phillip D. Zamore

Citations in the corpus

• MicroRNAs in development and disease. (2011, background): “Downregulation of miR-7 complements the suppression of the AKT inhibitor PTEN by miR-26a, by directly derepressing the translation of epidermal growth factor receptor (EGFR) and insulin receptor substrate-1, both of which contribute to activation of the AKT pathway (295).”
• Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. (2011, background): “Two recent studies reported post-transcriptional regulation of miR-7 biogenesis (Kefas et al., 2008; Wu et al., 2010).”